Healthcare provider profile · identity verified

Edward W. Bloom, MD

Family Practice · BELLINGHAM, WA · NPI 1720034838

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	537	144
Lisinopril	Lisinopril	343	94
Losartan Potassium	Losartan Potassium	311	82
Levothyroxine Sodium	Levothyroxine Sodium	244	53
Hydrochlorothiazide	Hydrochlorothiazide	196	57
Amlodipine Besylate	Amlodipine Besylate	189	52
Tamsulosin Hcl	Tamsulosin Hcl	172	54
Metformin Hcl	Metformin Hcl	167	47
Gabapentin	Gabapentin	156	41
Metoprolol Succinate	Metoprolol Succinate	146	47
Simvastatin	Simvastatin	131	33
Omeprazole	Omeprazole	127	40
Rosuvastatin Calcium	Rosuvastatin Calcium	110	33
Atenolol	Atenolol	101	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	79	19
Carvedilol	Carvedilol	67	17
Albuterol Sulfate Hfa	Albuterol Sulfate	65	38
Eliquis	Apixaban	61	13
Meloxicam	Meloxicam	61	23
Trazodone Hcl	Trazodone Hcl	61	21
Allopurinol	Allopurinol	58	15
Ozempic	Semaglutide	58	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	57	15
Metoprolol Tartrate	Metoprolol Tartrate	56	15
Potassium Chloride	Potassium Chloride	55	18
Duloxetine Hcl	Duloxetine Hcl	54	14
Sertraline Hcl	Sertraline Hcl	54	17
Alendronate Sodium	Alendronate Sodium	50	16
Furosemide	Furosemide	50	16
Donepezil Hcl	Donepezil Hcl	48	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	48	16
Oxycodone Hcl	Oxycodone Hcl	45	12
Fluticasone Propionate	Fluticasone Propionate	41	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	39	12
Metformin Hcl Er	Metformin Hcl	38	14
Clopidogrel	Clopidogrel Bisulfate	34	suppressed
Spironolactone	Spironolactone	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	23
Jardiance	Empagliflozin	29	suppressed
Cephalexin	Cephalexin	28	25
Clonazepam	Clonazepam	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Prednisone	Prednisone	23	18
Synthroid	Levothyroxine Sodium	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	13
Methocarbamol	Methocarbamol	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Spiriva Handihaler	Tiotropium Bromide	17	suppressed
Terbinafine Hcl	Terbinafine Hcl	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Naproxen	Naproxen	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Finasteride	Finasteride	15	suppressed
Glipizide	Glipizide	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Morphine Sulfate	Morphine Sulfate	15	suppressed
Estradiol	Estradiol	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Famotidine	Famotidine	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Primidone	Primidone	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Montelukast Sodium	Montelukast Sodium	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error